Cancer Treatment (IMAGE) University of Nebraska-Lincoln Caption The University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors. Led by researchers from the Wistar Institute, the team identified a protein that maliciously rewires immune cells and impedes cancer therapies. Inhibiting that protein with a compound developed by DiRusso's lab helped slow or even reject tumors associated with four different cancers. Credit Craig Chandler, University of Nebraska-Lincoln Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.